HALOZYME THERAPEUTICS INC (HALO)
US40637H1095 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 443.3M 65.66% | 660.1M 48.91% | 829.253M 25.63% | 1.023B 23.36% | 1.18B 15.35% | 1.434B 21.53% | 1.686B 17.57% | 1.825B 8.24% | 1.716B -5.97% | 1.59B -7.34% | 1.459B -8.24% | |
| EBITDA YoY % growth | 278.9M 88.96% | 339M 21.55% | 424.93M 25.35% | 571.73M 34.55% | 723.95M 26.62% | 1.002B 38.41% | 1.106B 10.38% | 1.218B 10.13% | 1.14B -6.40% | 1.046B -8.25% | N/A | |
| EBIT YoY % growth | 275.9M 91.20% | 289.4M 4.89% | 340.074M 17.51% | 542.19M 59.43% | 671.64M 23.88% | 875.91M 30.41% | 1.072B 22.39% | 1.226B 14.37% | 988.38M -19.38% | 904.74M -8.46% | 773.16M -14.54% | |
| Operating Margin | 62.24% | 43.84% | 41.01% | 53.00% | 56.92% | 61.08% | 63.58% | 67.18% | 57.60% | 56.90% | 52.99% | |
| EPS YoY % growth | 1.92 113.33% | 2.22 15.62% | 2.78 25.23% | 4.23 52.12% | 4.98 17.70% | 6.45 29.61% | 8.01 24.11% | 8.81 10.01% | 8.72 -0.97% | 8.29 -5.00% | 6.92 -16.55% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.20 46.16% | 1.06 34.28% | 1.20 31.70% | 1.29 1.20% | 1.37 14.04% |
| Revenue Q2Q % growth | 296.75M 29.00% | 262.83M 34.18% | 285.56M 23.43% | 301.2M 3.83% | 313.36M 5.60% |
| EBITDA Q2Q % growth | 192.43M 3.52% | 166.73M 44.05% | 179.63M 13.85% | 193.92M -13.46% | 213.57M 10.99% |
| EBIT Q2Q % growth | 165.57M 63.87% | 155.11M 62.35% | 175.38M 49.60% | 189.34M 16.02% | 197.8M 19.47% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.27 69.33% | 1.00 | 0.27 | 26.79% |
| Q2 2024 Q2Q % growth | 0.91 22.97% | 0.77 | 0.14 | 17.68% |
| Q1 2024 Q2Q % growth | 0.79 68.09% | 0.71 | 0.08 | 11.44% |
| Q4 2023 Q2Q % growth | 0.82 70.83% | 0.84 | -0.02 | -2.55% |
| Q3 2023 Q2Q % growth | 0.75 1.35% | 0.72 | 0.03 | 3.96% |
| Q2 2023 Q2Q % growth | 0.74 39.62% | 0.64 | 0.10 | 15.31% |
| Q1 2023 Q2Q % growth | 0.47 | 0.49 | -0.02 | -3.40% |
| Q4 2022 Q2Q % growth | 0.48 14.29% | 0.48 | 0.00 | 1.02% |
| Q3 2022 Q2Q % growth | 0.74 45.10% | 0.52 | 0.22 | 41.37% |
| Q2 2022 Q2Q % growth | 0.53 -14.52% | 0.51 | 0.02 | 3.58% |
| Q1 2022 Q2Q % growth | 0.47 27.03% | 0.50 | -0.03 | -5.96% |
| Q4 2021 Q2Q % growth | 0.42 -16.00% | 0.41 | 0.01 | 1.36% |
| Q3 2021 Q2Q % growth | 0.51 104.00% | 0.43 | 0.08 | 18.20% |
| Q2 2021 Q2Q % growth | 0.62 226.32% | 0.42 | 0.20 | 47.85% |
| Q1 2021 Q2Q % growth | 0.37 1,025.00% | 0.32 | 0.05 | 14.15% |
| Q4 2020 Q2Q % growth | 0.50 308.33% | 0.54 | -0.04 | -8.15% |
| Q3 2020 Q2Q % growth | 0.25 247.06% | 0.20 | 0.05 | 25.88% |
| Q2 2020 Q2Q % growth | 0.19 290.00% | 0.25 | -0.06 | -24.33% |
| Q1 2020 Q2Q % growth | -0.04 -500.00% | -0.02 | -0.02 | -89.17% |
| Q4 2019 Q2Q % growth | -0.24 -2,300.00% | -0.16 | -0.08 | -52.89% |
| Q3 2019 Q2Q % growth | -0.17 10.53% | -0.12 | -0.05 | -37.17% |
| Q2 2019 Q2Q % growth | -0.10 37.50% | -0.14 | 0.04 | 30.57% |
| Q1 2019 Q2Q % growth | 0.01 105.26% | 0.01 | 0.00 | -29.47% |
| Q4 2018 Q2Q % growth | -0.01 | -0.03 | 0.02 | 65.21% |
| Q3 2018 Q2Q % growth | -0.19 | -0.24 | 0.05 | 19.50% |
| Q2 2018 Q2Q % growth | -0.16 | -0.23 | 0.07 | 29.45% |
| Q1 2018 Q2Q % growth | -0.19 | -0.23 | 0.04 | 16.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 290.084M 34.28% | 256.08M | 34.004M | 13.28% |
| Q2 2024 Q2Q % growth | 231.353M 4.67% | 209.04M | 22.313M | 10.67% |
| Q1 2024 Q2Q % growth | 195.879M 20.81% | 203.77M | -7.891M | -3.87% |
| Q4 2023 Q2Q % growth | 230.039M 26.74% | 235.76M | -5.721M | -2.43% |
| Q3 2023 Q2Q % growth | 216.033M 3.37% | 220.43M | -4.397M | -1.99% |
| Q2 2023 Q2Q % growth | 221.038M 45.04% | 203.95M | 17.088M | 8.38% |
| Q1 2023 Q2Q % growth | 162.143M 38.23% | 179.02M | -16.877M | -9.43% |
| Q4 2022 Q2Q % growth | 181.5M 77.94% | 195.9M | -14.4M | -7.35% |
| Q3 2022 Q2Q % growth | 209M 80.48% | 194.93M | 14.07M | 7.22% |
| Q2 2022 Q2Q % growth | 152.4M 11.65% | 141.56M | 10.84M | 7.66% |
| Q1 2022 Q2Q % growth | 117.3M 31.80% | 130.82M | -13.52M | -10.33% |
| Q4 2021 Q2Q % growth | 102M -16.19% | 102.33M | -330K | -0.32% |
| Q3 2021 Q2Q % growth | 115.8M 77.34% | 107.74M | 8.06M | 7.48% |
| Q2 2021 Q2Q % growth | 136.5M 147.28% | 106.13M | 30.37M | 28.62% |
| Q1 2021 Q2Q % growth | 89M 250.39% | 86.576M | 2.424M | 2.80% |
| Q4 2020 Q2Q % growth | 121.7M 126.63% | 122.57M | -870K | -0.71% |
| Q3 2020 Q2Q % growth | 65.3M 41.34% | 62.12M | 3.18M | 5.12% |
| Q2 2020 Q2Q % growth | 55.2M 41.18% | 68.01M | -12.81M | -18.84% |
| Q1 2020 Q2Q % growth | 25.4M -55.36% | 43.821M | -18.421M | -42.04% |
| Q4 2019 Q2Q % growth | 53.7M -10.80% | 58.067M | -4.367M | -7.52% |
| Q3 2019 Q2Q % growth | 46.2M 80.47% | 56.031M | -9.831M | -17.55% |
| Q2 2019 Q2Q % growth | 39.1M 11.08% | 43.619M | -4.519M | -10.36% |
| Q1 2019 Q2Q % growth | 56.9M 84.14% | 69.159M | -12.259M | -17.73% |
| Q4 2018 Q2Q % growth | 60.2M | 60.967M | -767K | -1.26% |
| Q3 2018 Q2Q % growth | 25.6M | 31.032M | -5.432M | -17.50% |
| Q2 2018 Q2Q % growth | 35.2M | 30.691M | 4.509M | 14.69% |
| Q1 2018 Q2Q % growth | 30.9M | 32.475M | -1.575M | -4.85% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.29% | -0.18% | 4.63% |
| Revenue | 0% | 2.3% | 0% | 1.89% |